Bristol-Myers Squibb and Vedanta Biosciences Announce a New Clinical Collaboration to Evaluate OPDIVO (nivolumab) and VE800 in Patients with Advanced or Metastatic Cancers

Press/Media

Period10 Dec 2018

Media coverage

1

Media coverage

  • TitleBristol-Myers Squibb and Vedanta Biosciences Announce a New Clinical Collaboration to Evaluate OPDIVO (nivolumab) and VE800 in Patients with Advanced or Metastatic Cancers
    Media name/outletFirstWord Pharma
    Country/TerritoryUnited States
    Date10/12/18
    URLwww.firstwordpharma.com/node/1610323?tsid=1
    PersonsJeremiah Faith
View all 1
View less